Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκ B pathway

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Sun, Hai Jian ^a   Zhao, Ming Xia ^a   Liu, Tong Yan ^a   Ren, Xing Sheng ^a   Chen, Qi ^a   Li, Yue Hua ^a   Kang, Yu Ming ^b   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACAT1 PROTEIN, HUMAN; ACETYL COENZYME A ACETYLTRANSFERASE; CYBB PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIGNAL PEPTIDE; TOR2A PROTEIN, HUMAN; VASCULAR CELL ADHESION MOLECULE 1;

CELL ADHESION; CELL CULTURE; CYTOLOGY; FOAM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MONOCYTE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ACETYL-COA C-ACETYLTRANSFERASE; CELL ADHESION; CELLS, CULTURED; FOAM CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MICRORNAS; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84962239955     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23596     Document Type: Article

References (47)

1. Ullery-Ricewick, J. C., Cox, B. E., Griffin, E. E. & Jerome, W. G. Triglyceride alters lysosomal cholesterol ester metabolism in cholesteryl ester-laden macrophage foam cells. J Lipid Res 50, 2014-2026 (2009).
2. Khan, S. et al. Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep 4, 4680 (2014).
3. Angelovich, T. A., Hearps, A. C. & Jaworowski, A. Inflammation-induced foam cell formation in chronic inflammatory disease. Immunol Cell Biol 93, 683-693 (2015).
4. Chaabane, C., Coen, M. & Bochaton-Piallat, M. L. Smooth muscle cell phenotypic switch: Implications for foam cell formation. Curr Opin Lipidol 25, 374-379 (2014).
5. Rosenfeld, M. E. & Ross, R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10, 680-687 (1990).
6. Braunersreuther, V. & Mach, F. Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches? Cell Mol Life Sci 63, 2079-2088 (2006).
7. Ling, S., Nheu, L. & Komesaroff, P. A. Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini Rev Med Chem 12, 175-183 (2012).
8. Shichiri, M. et al. Salusins: Newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9, 1166-1172 (2003).
9. Suzuki, N. et al. Systemic distribution of salusin expression in the rat. Hypertens Res 30, 1255-1262 (2007).
10. Li, H. B. et al. Central blockade of salusin beta attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats. Sci Rep 5, 11162 (2015).
11. Chen, W. W. et al. Salusin-beta in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. Cardiovasc Res 98, 344-351 (2013).
12. Sun, H. J. et al. Superoxide anions involved in sympathoexcitation and pressor effects of salusin-beta in paraventricular nucleus in hypertensive rats. Acta Physiol (Oxf) 210, 534-545 (2014).
13. Zhang, L. L. et al. Salusin-beta in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats. J Hypertens 32, 1059-1067 (2014).
14. Sun, H. J. et al. Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta 1852, 1709-1718 (2015).
15. Watanabe, T. et al. Impact of salusin-alpha and-beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117, 638-648 (2008).
16. Nagashima, M. et al. Chronic infusion of salusin-alpha and-beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212, 70-77 (2010).
17. Fujimoto, K. et al. Circulating levels of human salusin-beta, a potent hemodynamic and atherogenesis regulator. Plos One 8, e76714 (2013).
18. Min, J. K. et al. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res 96, 300-307 (2005).
19. Yu, X. H., Fu, Y. C., Zhang, D. W., Yin, K. & Tang, C. K. Foam cells in atherosclerosis. Clin Chim Acta 424, 245-252 (2013).
20. Sato, K., Watanabe, R., Itoh, F., Shichiri, M. & Watanabe, T. Salusins: Potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens 2013, 965140 (2013).
21. Gerhardt, T. & Ley, K. Monocyte trafficking across the vessel wall. Cardiovasc Res 107, 321-330 (2015).
22. Hsu, W. Y. et al. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol 226, 2181-2188 (2011).
23. Doran, A. C., Meller, N. & McNamara, C. A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28, 812-819 (2008).
24. Wang, L., Qiu, X. M., Hao, Q. & Li, D. J. Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor beta mediating nitric oxide production and NF-kappaB suppression in endothelial cells. Cell Death Dis 4, e551 (2013).
25. Yan, S. et al. Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-alpha-treated endothelial cells via NADPH oxidase-dependent IkappaB kinase/NF-kappaB pathway. Free Radic Biol Med 78, 190-201 (2015).
26. Sato, J. et al. Family with sequence similarity 5, member C (FAM5C) increases leukocyte adhesion molecules in vascular endothelial cells: Implication in vascular inflammation. Plos One 9, e107236 (2014).
27. Zampetaki, A., Dudek, K. & Mayr, M. Oxidative stress in atherosclerosis: The role of microRNAs in arterial remodeling. Free Radic Biol Med 64, 69-77 (2013).
28. Chen, G. F. et al. Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function. Sci Rep 5, 14780 (2015).
29. Brandes, R. P. Vascular functions of NADPH oxidases. Hypertension 56, 17-21 (2010).
30. Sun, J. et al. Apocynin suppression of NADPH oxidase reverses the aging process in mesenchymal stem cells to promote osteogenesis and increase bone mass. Sci Rep 5, 18572 (2015).
31. Schober, A., Nazari-Jahantigh, M. & Weber, C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol 12, 361-374 (2015).
32. Nazari-Jahantigh, M. et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122, 4190-4202 (2012).
33. Du, F. et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 34, 759-767 (2014).
34. Yamamoto, K., Ohishi, M., Ho, C., Kurtz, T. W. & Rakugi, H. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation. Hypertension 54, 1353-1359 (2009).
35. Yin, Y. W. et al. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression. Cell Death Dis 5, e1574 (2014).
36. Jiagang, D. et al. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells. Biochem Biophys Res Commun 411, 523-529 (2011).
37. Usui, T., Okada, M., Hara, Y. & Yamawaki, H. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 60, 1031-1039 (2012).
38. Huttunen, H. J., Greco, C. & Kovacs, D. M. Knockdown of ACAT-1 reduces amyloidogenic processing of APP. FEBS Lett 581, 1688-1692 (2007).
39. Wang, P. C. et al. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Int J Mol Sci 15, 3560-3579 (2014).
40. Lei, L. et al. TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation. J Lipid Res 50, 1057-1067 (2009).
41. Liu, L., Hu, Y., Fu, J., Yang, X. & Zhang, Z. MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma. Journal of oral pathology & medicine: Official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 42, 140-147 (2013).
42. Liu, Y. et al. MicroRNA-155 Regulates ROS Production, NO Generation, Apoptosis and Multiple Functions of Human Brain Microvessel Endothelial Cells Under Physiological and Pathological Conditions. Journal of cellular biochemistry 116, 2870-2881 (2015).
43. Liang, C. J. et al. Viscolin reduces VCAM-1 expression in TNF-alpha-treated endothelial cells via the JNK/NF-kappaB and ROS pathway. Free Radic Biol Med 51, 1337-1346 (2011).
44. Zhong, Q. & Kowluru, R. A. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62, 2559-2568 (2013).
45. Hwang, H. J. et al. Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-kappaB pathways. Plos One 8, e76679 (2013).
46. Lv, L. et al. Lentivirus-mediated RNA interference targeting STAT4 inhibits the proliferation of vascular smooth muscle cells. Archives of medical research 39, 582-589 (2008).
47. Bruder-Nascimento, T. et al. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J Mol Cell Cardiol 66, 18-26 (2014).